Headache evaluation and management after concussion. Assistant Professor

Similar documents
Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.

Overview INTRODUCTION 3/15/2018. Headache Emergencies. Other way to differentiate between them? Is there an easy way to differentiate between them?

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches

Strategies in Migraine Care

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

Headaches in Pregnancy Before, During, and After

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

How do we treat migraine? New SIGN Guidelines

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

Headache. Headache Case. Migraine Headache. Eric Kraus, MD. Types» Without aura (common)» With aura (classic)

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy

Headache and Facial Pain. Mohammed ALEssa MBBS, FRCSC Assistant Professor Consultant Otolaryngology,Head & Neck Surgical Oncology

Treatment of Primary Headache Syndromes

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

HEADACHE. Dr Nick Pendleton. September Headache

The Pediatric Headache Handbook

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

A synopsis of: Diagnosis and Management of Headaches in Adults: A national clinical guideline. Scottish intercollegiate Guidelines Network SIGN

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

CHRONIC HEADACHES IN CHILDHOOD

25/09/2018 HEADACHE. Dr Nick Pendleton

Concussion Management. Michael Reardon, M.D. April 24,2016

Headache A Practical Approach

HEADACHES THE RED FLAGS

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

Welcome to the program!

Headache Mary D. Hughes, MD Neuroscience Associates

Heads Up: Concussion Management. Laurel Short, MSN, FNP-c

Outpatient Headache Care Guideline

General Patient Information Dr. David A. Branch, M.D.

Headache. Karen Thaxter

Treatments for migraine

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

Can I send this headache patient home? Dr Nicola Giffin Consultant Neurologist Bath, Nov 2017

Neurological Dilemmas in Primary Care

Headache Questionnaire

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

Headaches in the Pediatric Emergency Dept

Controlling Migraine Pain

1. On how many days in the last 3 months did you miss work or school because of your headaches?

Headache. Section 1. Migraine headache. Clinical presentation

Clinical Learning Days November 10, 2017

Lynne Kerr, MD May 2014

This policy addresses only the type B formulation rimabotulinumtoxinb marketed as Myobloc.

Paediatric headaches. Dr Jaycen Cruickshank Director of Clinical Training Ballarat Health Services. Brevity, levity, repetition

COLUMBIA UNIVERSITY HEADACHE CENTER: NEW PATIENT QUESTIONNAIRE

ADVANCES IN MIGRAINE MANAGEMENT

Adult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention

Disclosures. Triptans for Kids 5/16/13

10/13/17. Christy M. Jackson, MD Director, Dalessio Headache Center Scripps Clinic, La Jolla Clinical Professor, Neurosciences UCSD

Proposed Project Scope. OPTIMAL USE OnabotulinumtoxinA for the Prevention of Chronic Migraine Clinical Evidence, Policies and Practice

IT S ALL IN YOUR HEAD!

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Migraine in Children. Germano Falcao, MD Pediatric Neurology 03/07/2014

Headache Assessment In Primary Eye Care

What You Should Know About Your HEADACHE. Learn more about headache types, triggers, and treatments, when to get help, and how to help yourself

CONCUSSIONS. Recognition, Assessment, Management, and Return to Play

Understanding Migraines

6/4/2018. Headache. Headaches. Headache. Migraine Headaches. Headache. Red Flag signs and symptoms. Imaging CT without contrast.

How could I be having migraine when I don't have a headache?

Migraine, Tension, and Cluster Headache: Primary Care for Primary Headaches. Jonathon M. Firnhaber, MD, FAAFP

July 2012 Target Population. Adult patients 18 years or older in primary care settings.

Concussion Update and Case Presentations

Management of headache

Craig Davidson, MD University Health Center Team Physician Department of Athletic Medicine University of Oregon

June National Migraine and Headache Awareness Month

Discussion Questions WHAT ARE SOME POSSIBLE CAUSES OF HER PAIN? WHAT ELSE WOULD YOU LIKE TO KNOW

PAEDIATRIC ACUTE CARE GUIDELINE. Headache. This document should be read in conjunction with this DISCLAIMER

Dubai Standards of Care (Migraine)

MIGRAINE A MYSTERY HEADACHE

Chronic Daily Headaches

Refractory Headache Challenges and Strategies. David W. Dodick, M.D. Department of Neurology Mayo Clinic Phoenix Arizona USA

Disclosures. Objectives 6/2/2017

Common Headaches. Types and Natural Treatments

Triptan Quantity Limit

VA/DoD Clinical Practice Guideline for the Management of Concussion/mTBI

Lost in Translation: Making Sense of Clinical Treatment Guidelines

Primary Care Adult Headache Management Pathway (formerly North West Headache Management Guideline for Adults) Version 1.0

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 5/18/17 SECTION: DRUGS LAST REVIEW DATE: 5/17/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

Migraine Treatment What you need to know

2008 Migraine Update Migraine Update Migraine Update. Epidemiology. Yousef Mohammad MD., MSc. Epidemiology

Disclosures. Objectives 6/20/2018. No disclosures. Tools & Tips for Headache Management in Special Populations: The Young & Old, Pregnant & Lactating

Reflections on NICE Headache Guideline. Dr Kay Kennis GPwSI in Headache, Bradford

Treatment of Headache in the ED

Subject: CGRP Inhibitors

Headaches. Mini Medical School. November 10, A. Laine Green MSc, MD FRCP(C) Assistant Professor Department of Medicine (Neurology)

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

SPRINGFIELD CLINIC S

Kristin s Head Trauma Board Questions 11/07/14

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Transcription:

Headache evaluation and management after concussion Juliette Preston, M.D. Assistant Professor OHSU Headache Center

OVERVIEW Introduction Definition Acute post-traumatic headache Red flags Persistent post-traumatic headache Recognizing headache types Treatment options

INTRODUCTION Headache is one of the most common and persistent symptom following traumatic brain injury. An estimated 2.5 million reported TBIs per year in the USA alone ( Lucas. Curr Pain Headache Rep 2015) 75% of TBI are considered mild (Lucas et al. Cephalgia 2014)

Prevalence at 1 year? Prevalence remains high at over 44 % throughout the year after moderate or severe TBI and over 54 % after mild TBI (Lucas et al, Curr Pain Headache Rep, 2015).

DEFINITION The diagnostic criteria of ICHD-3 beta for all subtypes require that headache must be reported to have developed within 7 days of trauma or injury. or within 7 days after regaining consciousness and/or the ability to sense and report pain when these have been lost following trauma or injury. The International Classification of Headache Disorders, 3rd edition (beta version), 2013

Post traumatic headache attributed to moderate to severe injury to the head The International Classification of Headache Disorders, 3rd edition (beta version), 2013

Post traumatic headache attributed to mild injury to the head The International Classification of Headache Disorders, 3rd edition (beta version), 2013

DEFINITION During the first 3 months from onset they are considered acute. if they continue beyond that period they are designated persistent.

Acute post-traumatic headache Immediately following a head injury Want to identify the injury severity and other associated injuries The sideline or acute medical evaluation should include a systematic examination including how the trauma occurred symptoms following it presence of amnesia, memory problems or loss of consciousness, balance problems, and/or overall behavior change from baseline

If there are headaches History of headache prior to trauma Family history of headache Neuroimaging? Concern for skull or spine fracture if red flags are present

RED FLAGS Concern for intracranial process abnormalities or asymmetries on neurologic examination altered mental status worsening headache with Valsalva maneuver underlying risk factors such as hypercoagulable state (genetic or acquired, pregnancy, cancer) and anticoagulation therapy

CASE 1 28 yo woman presented to the ED with 5 day gradual persistent headache and scalp tenderness after a whiplash injury. She was rear ended at a stop sign. There was no LOC and she denies any balance difficulty, memory problem or overall behavior changes.

CASE 1 On examination she was normotensive and her temperature was also normal. There was no meningeal signs She had no neurological deficit CTH was unremarkable She was reassured and send home

CASE 1 The next morning, she noted difficulty in eating. She was able to swallow but found it difficult to move her tongue. She had no hoarseness. On examination her speech was dysarthric, and she had leftward deviation on tongue protrusion. Taste and tongue sensation were normal.

TONGUE WEAKNESS CN12 (HYPOGLOSSAL NERVE)

ARTERIAL DISSECTION MRA showed reduction in caliber of L ICA (A) And pseudoaneurysm (B)

CASE 1 She was started on ASA Repeat imaging were done at 6 weeks, slight improvement in L ICA was shown. At 3 months in f/u clinic visit, her speech had improved with only occasional dysarthria. She no longer reported headaches.

CASE 2 19 yo woman presented with 3 days of mild but constant headache after being hit by soccer ball while playing with her cousin. She complained of difficulty focusing and double vision.

CASE 2 Her past medical history is significant for knee surgery 2 months ago, had developed a DVT and was started on anticoagulation 4 weeks ago. On exam, vital signs are normal. BMI >25

CASE 2 Pupils were asymmetric Difficulty with adducting R eye CN 3 palsy

Normal MRI T1- weighted MRI: hyperintense sellar mass

PITUITARY APOPLEXY It s characterized by acute infarction and/or hemorrhage of the pituitary gland. Present with : Headache visual impairment cranial nerve palsies impairment of consciousness pituitary hormone deficiencies. In most cases, apoplexy involves a previously unrecognized pituitary adenoma.

Four categories of triggering factors Vascular flux reduction: surgery, specially cardiac surgery, radiotherapy, post spinal anesthesia. Acute increase in blood flow: pregnancy, systemic hypertension. Pituitary stimulation: provocative pituitary tests, specially TRH, GnRH analogues use. Coagulation disturbances: thrombocytopenia, anticoagulation.

Take home message.. Acute post traumatic headache with subtle neurological findings should be investigated.

PERSISTENT POST TRAUMATIC HEADACHE After 4-11 years, 500 veterans with TBI ( Couch et al, Headache, 2016) TBI - 89% had migraine, 2% probable migraine, 9% had tension, and 0% had no headaches. Control - 36% had migraine, 15% probable migraine, 27% tension, and 22% no headache (P <.0001). Migraine with aura occurred in 38% of TBI and 6% of control (P <.0001). There was no correlation of severity of headache problem with severity of TBI.

PERSISTENT POST TRAUMATIC HEADACHE The most common headache type after mtbi are migraine headache and tension-type headache. No randomized clinical trials of medication for posttraumatic headache in either children or adults. Management should be tailored to the type of headache.

CASE 3 20 yo man with pmh significant for ADHD, anxiety presented with daily headaches for 6 months. His headaches started after a second snowboard accident. Both event were separated by a few weeks. No LOC, hit his head, felt foggy afterward. Now he still reports difficulty concentrating (attending college, has a W on econ class)

CASE 3 His headaches are located in his temples, top of head and back of the head. Intensity varies between 2-4/10. No nausea, light, sound or smell sensitivity Physical activity does not aggravate his headaches.

CASE 3 Neurological exam is normal MRI brain done previously was unremarkable He is here with his mom who is very anxious

CASE 3 Diagnosis? A. Migraine headache B. Tension-type headache C. Non-classified headache type D. He doesn t have headaches

TENSION TYPE HEADACHE Definition: Bilateral location Pressing or tightening (non-pulsating) quality Mild intensity Not aggravated by routine physical activity such as walking or climbing stairs No nausea or vomiting No more than one of photophobia or phonophobia

DEFINITION MIGRAINE HEADACHE Unilateral location Pulsating quality Moderate or severe pain intensity Aggravation by or causing avoidance of routine physical activity (eg, walking or climbing stairs) Nausea, vomiting, or both Photophobia and phonophobia Last >4 hours

CASE 3 Diagnosis? A. Migraine headache B. Tension-type headache C. Non-classified headache D. He doesn t have headaches

TREATMENT TCA Amitriptyline ( 10-75 mg qhs) Nortriptyline ( 10-75 mg qhs ) Protriptyline ( 5-20 mg qam)-activating, weight loss SNRI- Venlafaxine ( 37.5-150 mg qam) Muscle relaxant-daily-not proven effective Botulinum toxin injection-not proven effective Trigger point injection-effective

CASE 3 Patient did well on 20 mg of Nortriptyline He reported 1-2 headaches per week Ibuprofen 400 mg sufficient to abort his headaches. After 6 months of good control, he didn t want to stop Nortriptyline.

CASE 4 18 yo woman with past medical history of migraine headache since age 9, who presented with daily headache for 2 years. She used to play basketball and had a handful of concussions, none with LOC. She had only 1 event associated with LOC, at age 16 she fell off her horse. She felt confused for 15 minutes. Her headaches worsen a few weeks afterwards.

CASE 4 Her headaches are located behind the right eye, in the forehead, temple and in the back of the head. The quality of the pain can be throbbing, pressurelike or stabbing. The intensity of the pain varies between 7-10/10. Her headaches are associated with nausea, sensitivity to light, sound, smell, touch, dizziness, fatigue and difficulty concentrating.

TRIED MEDICATION/INTERVENTION IN THE PAST 1. Topamax 2. Verapamil 3. Amitriptyline 4. Nortriptyline 5. Lamictal 6. Botox 7. Maxalt 8. Imitrex 9. Zomig NS 10. Toradol IM/IV-helpful 11. Occipital nerve-not effective

CASE 4 Currently she is no preventative since nothing ever works for me She only uses Advil or Excedrin to break her headaches.

CASE 4 Diagnosis? A. Migraine headache B. Tension-type headache C. Non-classified headache type D. She doesn t have headaches

CASE 4 Diagnosis? A. Migraine headache B. Tension-type headache C. Non-classified headache type D. She doesn t have headaches

With prompting She admits using 2-3 tablets of either Advil or Excedrin daily. Does that change her diagnosis?

No #1 Migraine Headache #2 Medication overuse headache

MOH Criteria

Which drugs? Bigal et al. (2008, Headache) found that barbiturates (butalbital combinations) can cause MOH if used only 5 or more days per month. Opioids if taken 8 days or more per month Triptans if taken 10 or more days per month. Non-steroidal anti-inflammatory drugs (NSAIDs), if if taken 10 or more days per month.

CASE 4 Stop daily Advil/Excedrin Bridging therapy (protocol) x 6 weeks long acting NSAIDs ( Naproxen 500 mg bid) + muscle relaxant (Tizanidine 2-16mg qhs) Smith. Headache 2002 Start Venlafaxine 37.5 mg x 2 weeks, then increased to 75 mg qam. Retrial of Rizatriptan ( 10 mg) to break her headaches

At 2 months visit She felt like a new person She reports now only 2-4 headaches per month responsive to Rizatriptan ( which did not work in the past). Rizatriptan (10 mg, max 30 mg/24 hrs) was chosen as with Eletriptan ( 40 mg, max 80 mg/24 hrs), they are most potent triptans.

When to consider Preventive Treatment? Use acute medications more than 10 days per month No longer responsive to rescue medication Side effects from acute treatment Affect patient daily life-home, work, or school

TREATMENT OPTIONS Beta blocker: Propranolol 40-240 mg daily or bid if short acting, 1-2 mg/kg in children Metoprolol 50-200 mg daily Nadolol 20-120 mg daily, fewer side effects than propranolol Atenolol 25-150 mg daily- fewer side effects than propranolol, more suitable for pts with chronic lung disease/asthma at lower dose

Antiepileptic drugs Level A evidence (stablished efficacy) Topiramate: 25-125 mg qhs ( not effective above 200 mg /day) Valproate/divalproex: 500-2000 mg daily

TREATMENT Antidepressant level B evidence (probably effective) Amitriptyline ( 10 mg -75 mg qhs) Venlafaxine ( 37.5 mg- 150 mg qam) Level C evidence ( possibly effective) Lisinopril 10-40 mg daily Candesartan 16-32 mg daily Cyproheptadine (12-32 mg bid or qhs)- children/pregnant patient Level U ( inadequate or conflicting data): Acetazolamide, Fluoxetine, Gabapentin, Verapamil

Complementary Alternative therapy Physical activity ( 40 min x 3 w) Acupuncture Nutraceuticals Magnesium citrate 400 mg daily Riboflavin 400 mg daily or 200 mg twice a day Coenzyme Q10 300-600 mg qam Biobehavioral treatment CBT Thermal biofeedback with relaxation Relaxation training

REVIEW Post traumatic headaches are very common and persistent Treated like a primary headache disorder Mild headache, not aggravated by movement tension-type headache Moderate to severe headache, pt wants to be still migraine headache Headaches with any neurological symptoms Neuroimaging/ED

Thank You